Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Gynecology

  Free Subscription


Articles published in Gynecol Endocrinol

Retrieve available abstracts of 290 articles:
HTML format



Single Articles


    December 2023
  1. SUN H, Yuan M, Wang X, Jiao X, et al
    Clinical efficacy and safety of trimonthly administration of goserelin acetate 10.8 mg in premenopausal Chinese females with symptomatic adenomyosis: a prospective cohort study.
    Gynecol Endocrinol. 2023;39:2160435.
    PubMed     Abstract available


  2. SHEIDA A, Davar R, Tabibnejad N, Eftekhar M, et al
    The effect of adding L-Carnitine to the GnRH-antagonist protocol on assisted reproductive technology outcome in women with polycystic ovarian syndrome: a randomized clinical trial.
    Gynecol Endocrinol. 2023;39:1878135.
    PubMed     Abstract available


  3. HU L, Liu Y, Dong P, Ye P, et al
    Protective effect of wuzibushen recipe on follicular development via regulating androgen receptor in polycystic ovary syndrome model rats.
    Gynecol Endocrinol. 2023;39:2190808.
    PubMed     Abstract available


  4. HOSSEINI E, Mokhtari Z, Salehi Abargouei A, Mishra GD, et al
    Maternal circulating leptin, tumor necrosis factor-alpha, and interleukine-6 in association with gestational diabetes mellitus: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2023;39:2183049.
    PubMed     Abstract available


  5. RUAN X
    Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China.
    Gynecol Endocrinol. 2023;39:2146671.
    PubMed     Abstract available


  6. CUI S, Zhu X, Li S, Zhang C, et al
    Study on the predictive value of serum hypersensitive C-reactive protein, homocysteine, fibrinogen, and omentin-1 levels with gestational diabetes mellitus.
    Gynecol Endocrinol. 2023;39:2183046.
    PubMed     Abstract available


  7. XING S, Guo Z, Lang J, Zhou M, et al
    N-Acetyl-l-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress.
    Gynecol Endocrinol. 2023;39:2189969.
    PubMed     Abstract available


  8. ZHOU J, Liu F, Tian L, Yang M, et al
    Mutational analysis of minichromosome maintenance complex component (MCM) family genes in Chinese Han women with polycystic ovarian syndrome.
    Gynecol Endocrinol. 2023;39:2206912.
    PubMed     Abstract available


  9. JIANG L, Ruan X, Li Y, Gu M, et al
    Diagnostic value of anti-Mullerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2206927.
    PubMed     Abstract available


  10. FERNANDEZ-SANCHEZ M, Fatemi H, Garcia-Velasco JA, Heiser PW, et al
    Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach.
    Gynecol Endocrinol. 2023;39:2205952.
    PubMed     Abstract available


  11. SHABITI Y, Wufuer S, Tuohuti R, Yun T, et al
    Impact of biomimetic electrical stimulation combined with Femoston on pregnancy rate and endometrium characteristics in infertility patients with thin endometrium: a prospective observational study.
    Gynecol Endocrinol. 2023;39:2214629.
    PubMed     Abstract available


  12. YILMAZ N, Gulsen Coban P, Yilmaz S, Inal HA, et al
    Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?
    Gynecol Endocrinol. 2023;39:2217295.
    PubMed     Abstract available


  13. GAO M, Tao X, Zhang Q, He W, et al
    Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2215869.
    PubMed     Abstract available


  14. KOVALAK EE, Karacan T, Zengi O, Karabay Akgul O, et al
    Evaluation of new biomarkers in stage III and IV endometriosis.
    Gynecol Endocrinol. 2023;39:2217290.
    PubMed     Abstract available


  15. XU S, Wang X, Zhang Y, Han Y, et al
    Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function.
    Gynecol Endocrinol. 2023;39:2217263.
    PubMed     Abstract available


  16. PAN Y, Li F, Yang CX, Sun Y, et al
    Correlation between different endometrial preparation protocols and pregnancy outcome of frozen embryo transfer in patients with polycystic ovary syndrome: a retrospective study.
    Gynecol Endocrinol. 2023;39:2217260.
    PubMed     Abstract available


  17. ZHAO J, Fu S, Chen Q
    Association between the serum vitamin D level and prevalence of obesity/abdominal obesity in women with infertility: a cross-sectional study of the National Health and Nutrition Examination Survey data.
    Gynecol Endocrinol. 2023;39:2217251.
    PubMed     Abstract available


  18. WU R, Chen Z, Xu W, Yang C, et al
    Impact of having surplus blastocysts cryopreserved on the ongoing pregnancy rate following a fresh transfer.
    Gynecol Endocrinol. 2023;39:2217281.
    PubMed     Abstract available


  19. ZHANG X, Liang L, Hu Y, Zhang Z, et al
    A thinner endometrium is associated with lower newborn birth weight during in vitro fertilization-frozen-embryo transfer: a cohort study.
    Gynecol Endocrinol. 2023;39:2217269.
    PubMed     Abstract available


  20. SEKIGUCHI M, Ito A, Fukuda Y, Yoneyama M, et al
    Optimal timing to retrieve oocytes for fertility preservation in patients with acute myeloid leukemia: two cases of controlled ovarian stimulation using DuoStim with a literature review.
    Gynecol Endocrinol. 2023;39:2217262.
    PubMed     Abstract available


  21. TIAN X, Ruan X, Du J, Cheng J, et al
    Sexual function in Chinese women with different clinical phenotypes of polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2221736.
    PubMed     Abstract available


  22. GAN J, Chen J, Ma RL, Deng Y, et al
    Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone.
    Gynecol Endocrinol. 2023;39:2219342.
    PubMed     Abstract available


  23. ANGIONI S, Saponara S, Vitale SG
    Metabolomics analysis in endometriosis patients: is it a step toward the future?
    Gynecol Endocrinol. 2023;39:2227276.
    PubMed    


  24. LI J, Chen S, Qin R, Liu X, et al
    Talin1 regulates glucose metabolism and endometrial receptivity via GLUT-4 in patients with polycystic ovary syndrome and insulin resistance.
    Gynecol Endocrinol. 2023;39:2231085.
    PubMed     Abstract available


  25. GE X, Zhang J, Shi H, Bu Z, et al
    Effect of blastocyst morphology on the incidence of monozygotic twinning pregnancy after single blastocyst transfer.
    Gynecol Endocrinol. 2023;39:2228434.
    PubMed     Abstract available


  26. CHAKRABARTI S
    Ovarian reserve analysis in subfertile women based on physical, ultrasound and hormonal parameters.
    Gynecol Endocrinol. 2023;39:2214616.
    PubMed     Abstract available


  27. LUO L, Shen Y, Ning D, Tang M, et al
    Chao Nang Qing prescription promotes granulosa cell apoptosis and autophagy by targeting GATA3.
    Gynecol Endocrinol. 2023;39:2223724.
    PubMed     Abstract available


  28. ORNAGHI S, Fernicola F, Marelli E, Perotti M, et al
    Acute spontaneous non-hemorrhagic adrenal infarction in pregnancy: case-report and literature review.
    Gynecol Endocrinol. 2023;39:2234492.
    PubMed     Abstract available


  29. SANCHEZ-ZARZA SC, Armeni AK, Chedraui P, Perez-Lopez FR, et al
    Prevalence of menopausal symptoms and severity related factors among mid-aged Paraguayan women as measured with the 10-item Cervantes Scale.
    Gynecol Endocrinol. 2023;39:2235427.
    PubMed     Abstract available


  30. PAN X
    Metabolic characteristics of obese patients with polycystic ovarian syndrome: a meta-analysis.
    Gynecol Endocrinol. 2023;39:2239934.
    PubMed     Abstract available


  31. LI H, Yang H, Lu S, Wang X, et al
    Autophagy-dependent ferroptosis is involved in the development of endometriosis.
    Gynecol Endocrinol. 2023;39:2242962.
    PubMed     Abstract available


  32. YAMANAKA K, Washio K, Uchida A, Sasagawa Y, et al
    Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix.
    Gynecol Endocrinol. 2023;39:2237121.
    PubMed     Abstract available


  33. LIU H, Li Q, Liu T, Tang Y, et al
    Trimester-specific reference intervals of serum homocysteine levels for pregnant women: a longitudinal study in China.
    Gynecol Endocrinol. 2023;39:2242974.
    PubMed     Abstract available


  34. NAVARRO-MARTINEZ H, Flores-Le Roux JA, Llaurado G, Gortazar L, et al
    One abnormal value or vomiting after oral glucose tolerance test in pregnancy: incidence and impact on maternal-fetal outcomes.
    Gynecol Endocrinol. 2023;39:2242951.
    PubMed     Abstract available


  35. MNATZAGANIAN G, Taylor M, He F, Yuen N, et al
    Differences in neonatal adverse outcomes among women with gestational diabetes mellitus managed by diet or medication: a propensity score matched analysis of a population-based sample.
    Gynecol Endocrinol. 2023;39:2250005.
    PubMed     Abstract available


  36. GENAZZANI AR, Fidecicchi T, Arduini D, Giannini A, et al
    Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice.
    Gynecol Endocrinol. 2023;39:2247093.
    PubMed     Abstract available


  37. BI B, Han X, Dai W, Fang L, et al
    Comparisons of different treatment outcomes in IVF/ET patients with hydrosalpinx: a retrospective study.
    Gynecol Endocrinol. 2023;39:2249999.
    PubMed     Abstract available


  38. RUAN X, Xu Z, Xu X, Yang Y, et al
    A prospective study on the endometrium properties and the pregnancy rate of infertile women with thin endometrium receiving Fructus ligustri lucidi used in traditional Chinese medicine.
    Gynecol Endocrinol. 2023;39:2249997.
    PubMed     Abstract available


  39. LI B, Zhang Y, Zhang L, Zhang L, et al
    Association between endometriosis and metabolic syndrome: a cross-sectional study based on the National Health and Nutrition Examination Survey data.
    Gynecol Endocrinol. 2023;39:2254844.
    PubMed     Abstract available


  40. JIN J, Ruan X, Hua L, Mueck AO, et al
    Prevalence of metabolic syndrome and its components in Chinese women with premature ovarian insufficiency.
    Gynecol Endocrinol. 2023;39:2254847.
    PubMed     Abstract available


  41. NAPPI RE, Farris M, Gallina Toschi A, Michieli R, et al
    Overcoming barriers to oral contraception in Italy an expert opinion to empower women.
    Gynecol Endocrinol. 2023;39:2254400.
    PubMed     Abstract available


  42. YE Y, Zhou W, Ren Y, Lu J, et al
    The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-kappaB and Nrf2/HO-1 pathways.
    Gynecol Endocrinol. 2023;39:2254848.
    PubMed     Abstract available


  43. WEI SX, Wang L, Liu YB, Fan QL, et al
    TPOAb positivity can impact ovarian reserve, embryo quality, and IVF/ICSI outcomes in euthyroid infertile women.
    Gynecol Endocrinol. 2023;39:2266504.
    PubMed     Abstract available


  44. HUANG J, Jiao X, You Y, Wu Y, et al
    The effects of different endometrial preparation regimens on pregnancy outcomes in frozen-thawed embryo transfer cycles: a prospective randomized controlled study.
    Gynecol Endocrinol. 2023;39:2269235.
    PubMed     Abstract available


  45. WANG XX, Hua T, Wang HB
    Estrogen receptor-related receptor gamma uppresses hypoxia-induced angiogenesis by regulating VEGFA in endometrial cancer.
    Gynecol Endocrinol. 2023;39:2264411.
    PubMed     Abstract available


  46. PALACIOS S, Ayala G, Gonzalez G, Badilla-Apuy CL, et al
    Combined oral contraceptives: update recommendations of the Latin American contraceptive association.
    Gynecol Endocrinol. 2023;39:2271072.
    PubMed     Abstract available


  47. WANG H, Liang W, Su W, Cui H, et al
    Expression and significance of silent information regulator two homolog 1 in the placenta and plasma of patients with pre-eclampsia-a meta-analysis.
    Gynecol Endocrinol. 2023;39:2264983.
    PubMed     Abstract available


  48. ZHOU W, Chen A, Ye Y, Ren Y, et al
    LIPUS combined with TFSC alleviates premature ovarian failure by promoting autophagy and inhibiting apoptosis.
    Gynecol Endocrinol. 2023;39:2258422.
    PubMed     Abstract available


  49. LI J, Zhu H, Zhu Y, Wu P, et al
    Effect of Bushen Huoxue recipe on serum metabolomics in polycystic ovary syndrome rats.
    Gynecol Endocrinol. 2023;39:2260500.
    PubMed     Abstract available


  50. WANG H, Ma X, Jiang Z, Xia D, et al
    Estrogen promotes the proliferation and migration of endometrial cancer cells by upregulating the expression of lncRNA HOTAIR.
    Gynecol Endocrinol. 2023;39:2269248.
    PubMed     Abstract available


  51. QI Q, Xia Y, Luo J, Wang Y, et al
    Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.
    Gynecol Endocrinol. 2023;39:2269281.
    PubMed     Abstract available


  52. LI Y, Wang N, Jing Y, He J, et al
    Down-regulation of the FTO gene in follicular fluid of infertile women with ovarian endometriosis.
    Gynecol Endocrinol. 2023;39:2269273.
    PubMed     Abstract available


  53. CHANG H, Ge H, Wu Q, Li J, et al
    Is elevated baseline SHBG associated with increased ovulation?
    Gynecol Endocrinol. 2023;39:2263085.
    PubMed     Abstract available


  54. CANCELO MJ, Sanchez Borrego R, Palacios S, Baquedano L, et al
    Vulvovaginal atrophy in the CRETA study: the healthcare professionals' perception.
    Gynecol Endocrinol. 2023;39:2264405.
    PubMed     Abstract available


  55. WANG NN, Tang M, Zhang HY, Yang QZ, et al
    Association between leptin receptor polymorphisms and polycystic ovary syndrome risk: a meta-analysis based on 11 studies.
    Gynecol Endocrinol. 2023;39:2279565.
    PubMed     Abstract available


  56. LIU XN, Cheng ZP
    Expression of high-mobility group box-1 in eutopic/ectopic endometrium and correlations with inflammation-related factors in adenomyosis.
    Gynecol Endocrinol. 2023;39:2269265.
    PubMed     Abstract available


  57. ZHAO X, Shi W, Liu X, Zhang W, et al
    Emerging trends and research priorities in premature ovarian insufficiency genes: a bibliometric and visualization study.
    Gynecol Endocrinol. 2023;39:2283033.
    PubMed     Abstract available


    November 2023

  58. Statement of Retraction: Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial.
    Gynecol Endocrinol. 2023 Nov 7:2272096. doi: 10.1080/09513590.2023.2272096.
    PubMed    


    October 2023
  59. JING YX, Li HX, Yue F, Li YM, et al
    N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
    Gynecol Endocrinol. 2023;39:2276167.
    PubMed     Abstract available


  60. MU X, Liu X, Zhou H, Shi J, et al
    The natural cycle protocol of endometrial preparation for frozen embryo transfer decreases the miscarriage rate in women with recurrent pregnancy loss.
    Gynecol Endocrinol. 2023;39:2269269.
    PubMed     Abstract available


  61. XU H, Wang C, Wei H, Li T, et al
    A novel missense variant in LAMC1 identified in a POI family by whole exome sequencing.
    Gynecol Endocrinol. 2023;39:2265507.
    PubMed     Abstract available


    August 2023
  62. JANSA V, Osredkar J, Verdenik I, Rizner TL, et al
    Oxidative stress markers cannot be used as endometriosis biomarkers in infertile patients.
    Gynecol Endocrinol. 2023;39:2242956.
    PubMed     Abstract available


  63. JIN J, Ruan X, Hua L, Mueck AO, et al
    Prevalence of diminished ovarian reserve in Chinese women with follicular cysts and menstrual disorders.
    Gynecol Endocrinol. 2023;39:2250004.
    PubMed     Abstract available


  64. VENTURELLA R, Rechberger T, Zatik J, Wagman RB, et al
    Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials.
    Gynecol Endocrinol. 2023;39:2249107.
    PubMed     Abstract available


  65. SHEN C, Jiang Y, Lin J, He Y, et al
    SIRT6 reduces the symptoms of premature ovarian failure and alleviates oxidative stress and apoptosis in granulosa cells by degrading p66SHC via H3K9AC.
    Gynecol Endocrinol. 2023;39:2250003.
    PubMed     Abstract available


  66. LEE HJ, Park MJ, Heo JD, Joo BS, et al
    Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model.
    Gynecol Endocrinol. 2023;39:2247094.
    PubMed     Abstract available


  67. MOURSI MO, Salem H, Ibrahim AR, Marzouk S, et al
    The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2247098.
    PubMed     Abstract available


  68. NAPPI RE, Panay N, Palacios S, Banerji V, et al
    Using advanced analytics to help identify women who are more likely to have a severe subjective experience of vulvovaginal atrophy: a modeling study.
    Gynecol Endocrinol. 2023;39:2245479.
    PubMed     Abstract available


  69. WANG C, Yu J, Ding C, Chen C, et al
    CangFu Daotan decoction improves polycystic ovarian syndrome by downregulating FOXK1.
    Gynecol Endocrinol. 2023;39:2244600.
    PubMed     Abstract available


    July 2023
  70. GRANDI G, Facchinetti F, Melotti C, Sgandurra A, et al
    Phyto-progestins for the treatment of abnormal uterine bleeding without organic cause in women at high risk for breast cancer and breast cancer survivors: a prospective, pilot study.
    Gynecol Endocrinol. 2023;39:2239936.
    PubMed     Abstract available


  71. WEI Z, Chen Z, Xiao W, Wu G, et al
    A systematic review and meta-analysis of the correlation between polycystic ovary syndrome and irritable bowel syndrome.
    Gynecol Endocrinol. 2023;39:2239933.
    PubMed     Abstract available


  72. LI H, Li Y, Zhang Y, Tong L, et al
    Rubus chingii Hu relieved the polycystic ovary syndrome with enhanced insulin sensitivity through inhibiting TXNIP/NLRP3 inflammasome signaling.
    Gynecol Endocrinol. 2023;39:2237116.
    PubMed     Abstract available


    June 2023
  73. WANG F, Yin Y, Nie X, Zou Y, et al
    Protocatechuic acid alleviates polycystic ovary syndrome symptoms in mice by PI3K signaling in granulosa cells to relieve ROS pressure and apoptosis.
    Gynecol Endocrinol. 2023;39:2228917.
    PubMed     Abstract available


  74. LONG X, Liu H, Xiong W, Li W, et al
    Low dose of liraglutide combined with metformin leads to a significant weight loss in Chinese Han women with polycystic ovary syndrome: a retrospective study.
    Gynecol Endocrinol. 2023;39:2223648.
    PubMed     Abstract available


  75. SU S, Zhang E, Gao S, Zhang Y, et al
    Serum uric acid and the risk of gestational diabetes mellitus: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2023;39:2231101.
    PubMed     Abstract available


  76. PINGARRON SANTOFIMIA C, Poyo Torcal S, Lopez Verdu H, Henriquez Linares A, et al
    Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2227277.
    PubMed     Abstract available


  77. CHEN C, Jiang X, Ding C, Sun X, et al
    Downregulated lncRNA HOTAIR ameliorates polycystic ovaries syndrome via IGF-1 mediated PI3K/Akt pathway.
    Gynecol Endocrinol. 2023;39:2227280.
    PubMed     Abstract available


  78. CASSIOLI E, Rossi E, Melani G, Faldi M, et al
    The menstrual distress questionnaire (MEDI-Q): reliability and validity of the English version.
    Gynecol Endocrinol. 2023;39:2227275.
    PubMed     Abstract available


    May 2023
  79. RUAN X, Li M, Min M, Ju R, et al
    Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2216807.
    PubMed     Abstract available


  80. BOUNOUS VE, Actis S, Rosso R, Giorgi M, et al
    No-daily hormonal contraception today: general overview and application in specific clinical settings.
    Gynecol Endocrinol. 2023;39:2214626.
    PubMed     Abstract available


  81. WU P, Zhu Y, Li J, Chen H, et al
    Guizhi Fuling Wan inhibits autophagy of granulosa cells in polycystic ovary syndrome mice via H19/miR-29b-3p.
    Gynecol Endocrinol. 2023;39:2210232.
    PubMed     Abstract available


  82. JI L, Jin L, Shao MJ, Hu M, et al
    Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.
    Gynecol Endocrinol. 2023;39:2208667.
    PubMed     Abstract available


  83. MOUSA S, Saif A, Fathy M, Mansour M, et al
    Assessment of early vascular changes in adult females with polycystic ovary syndrome: correlation with insulin resistance.
    Gynecol Endocrinol. 2023;39:2210226.
    PubMed     Abstract available


    April 2023
  84. YOUNESI ASL L, Kashanian M, Najmi Z, Mahdavi A, et al
    Risk factors of osteoporosis and osteopenia in postmenopausal women based on the L2-L4 BMD T score of the lumbar spine: a study in Iran.
    Gynecol Endocrinol. 2023;39:2205959.
    PubMed     Abstract available


    March 2023
  85. ARYEE NA, Adu-Bonsaffoh K, Arko-Boham B, Quaye O, et al
    Thyroid hormone profile in preeclampsia patients: a case control study.
    Gynecol Endocrinol. 2023 Mar 16:2186136. doi: 10.1080/09513590.2023.2186136.
    PubMed     Abstract available


  86. NAPPI RE, Tiranini L, Bosoni D, Cucinella L, et al
    Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.
    Gynecol Endocrinol. 2023 Mar 14:2189971. doi: 10.1080/09513590.2023.2189971.
    PubMed     Abstract available


  87. MATEMANOSAK P, Peeyananjarassri K, Suwanrath C, Wattanakumtornkul S, et al
    Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review.
    Gynecol Endocrinol. 2023 Mar 6:2186138. doi: 10.1080/09513590.2023.2186138.
    PubMed     Abstract available


    February 2023
  88. YU F, Xue Y, Zhao Y, Zhang L, et al
    Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
    Gynecol Endocrinol. 2023 Feb 26:2183045. doi: 10.1080/09513590.2023.2183045.
    PubMed     Abstract available


  89. LIANG Y, Xu ML, Gao X, Wang Y, et al
    Resveratrol improves ovarian state by inhibiting apoptosis of granulosa cells.
    Gynecol Endocrinol. 2023 Feb 23:2181652. doi: 10.1080/09513590.2023.2181652.
    PubMed     Abstract available


  90. SHU M, Yao S, Zhong W, Song C, et al
    Personalized embryo transfer based on RNA sequencing endometrial receptivity test in repeated implantation failure patients: artificial cycle versus natural cycle.
    Gynecol Endocrinol. 2023 Feb 23:2181639. doi: 10.1080/09513590.2023.2181639.
    PubMed     Abstract available


  91. ZHANG Y, Zhou H, Ding C
    The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.
    Gynecol Endocrinol. 2023 Feb 23:2181637. doi: 10.1080/09513590.2023.2181637.
    PubMed     Abstract available


  92. WEI J, Cheng P, Kong M, Zhang L, et al
    MicroRNA-23a-3p overexpression represses proliferation and accelerates apoptosis of granular cells in polycystic ovarian syndrome by targeting HMGA2.
    Gynecol Endocrinol. 2023 Feb 21:2172155. doi: 10.1080/09513590.2023.2172155.
    PubMed     Abstract available


  93. YANG X, Xiaoping W, Nan D, Jian Z, et al
    Proteomic and bioinformatic analysis of human endometrium from polycystic ovarian syndrome with and without insulin resistance.
    Gynecol Endocrinol. 2023 Feb 7:2173948. doi: 10.1080/09513590.2023.2173948.
    PubMed     Abstract available


  94. VANNUCCINI S, Petraglia F
    Adenomyosis: is an endocrine-related uterine dysfunction?
    Gynecol Endocrinol. 2023 Feb 3:2172156. doi: 10.1080/09513590.2023.2172156.
    PubMed    


    January 2023
  95. YANG H, Chen Y, Liu C
    Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023 Jan 28:2172154. doi: 10.1080/09513590.2023.2172154.
    PubMed     Abstract available


  96. VON STOCKUM S, Becker K, Bauerfeind A, Franke C, et al
    NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
    Gynecol Endocrinol. 2023 Jan 23:1-5. doi: 10.1080/09513590.2023.2166032.
    PubMed     Abstract available


  97. ZHENG R, Lin C, Mao Y, Jin F, et al
    miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis.
    Gynecol Endocrinol. 2023 Jan 19:2166483. doi: 10.1080/09513590.2023.2166483.
    PubMed     Abstract available


  98. ZHANG H, Chen Z, Wang X
    Differentiated serum levels of Kruppel-like factors 2 and 4, sP-selectin, and sE-selectin in patients with gestational diabetes mellitus.
    Gynecol Endocrinol. 2023 Jan 19:1-4. doi: 10.1080/09513590.2022.2164762.
    PubMed     Abstract available


  99. ZHONG M, Tu Y, Peng X, Song Y, et al
    A case of polycystic ovary syndrome with inevitable miscarriage and multi-site venous thrombosis caused by hereditary protein C deficiency.
    Gynecol Endocrinol. 2023 Jan 12:1-5. doi: 10.1080/09513590.2022.2162034.
    PubMed     Abstract available


  100. VON STOCKUM S, Bauerfeind A, Becker K, Franke C, et al
    NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study.
    Gynecol Endocrinol. 2023 Jan 8:1-6. doi: 10.1080/09513590.2022.2162036.
    PubMed     Abstract available


  101. BESTEL A, Elmas B, Gunkaya OS, Bestel M, et al
    Could sestrin protein in serum be a new marker of oxidative stress in patients with polycystic ovary syndrome?
    Gynecol Endocrinol. 2023 Jan 4:1-5. doi: 10.1080/09513590.2022.2163234.
    PubMed     Abstract available


  102. WEN Y, Fan L, Pang L, Zhao T, et al
    NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP.
    Gynecol Endocrinol. 2023 Jan 2:1-11. doi: 10.1080/09513590.2022.2162495.
    PubMed     Abstract available


    December 2022
  103. BAKIRCI S, Sagsoz N, Devrim T, Sahin Y, et al
    Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
    Gynecol Endocrinol. 2022 Dec 29:1-4. doi: 10.1080/09513590.2022.2163233.
    PubMed     Abstract available


  104. ARTAR G, Tas B, Turan G, Uckan HH, et al
    Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS).
    Gynecol Endocrinol. 2022 Dec 29:1-5. doi: 10.1080/09513590.2022.2162496.
    PubMed     Abstract available


  105. XU Z, Zhao H, Yue C, Zhang L, et al
    Low STING expression promotes endometrial stromal cell invasion and migration via the STING/IRF-3/IFN-beta1 pathway in eutopic endometrium of women with endometriosis.
    Gynecol Endocrinol. 2022 Dec 12:1-7. doi: 10.1080/09513590.2022.2154338.
    PubMed     Abstract available


  106. PEREZ-LOPEZ FR, Lopez-Baena MT, Perez-Roncero GR, Chedraui P, et al
    Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Dec 8:1-11. doi: 10.1080/09513590.2022.2152790.
    PubMed     Abstract available


  107. MORETTI C, Lazzarin N, Vaquero E, Dal Lago A, et al
    A practical approach to the management of thyroid dysfunction during pregnancy.
    Gynecol Endocrinol. 2022 Dec 8:1-7. doi: 10.1080/09513590.2022.2154337.
    PubMed     Abstract available


  108. PERALTA S, Solernou R, Barral Y, Roca J, et al
    Antral follicle count measured at down-regulation as predictor of ovarian response and cumulative live birth: single center analysis including 2731 long agonist IVF cycles.
    Gynecol Endocrinol. 2022 Dec 7:1-8. doi: 10.1080/09513590.2022.2154339.
    PubMed     Abstract available


  109. HOSSEIN RASHIDI B, Shahrokh Tehraninejad E, Amanpour S, Bandarian F, et al
    The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial.
    Gynecol Endocrinol. 2022;38:1087-1092.
    PubMed     Abstract available


  110. JIAO G, Lian H, Xing J, Chen L, et al
    MOS mutation causes female infertility with large polar body oocytes.
    Gynecol Endocrinol. 2022;38:1158-1163.
    PubMed     Abstract available


  111. UNANYAN A, Pivazyan L, Krylova E, Eskin A, et al
    Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis.
    Gynecol Endocrinol. 2022;38:1035-1046.
    PubMed     Abstract available


    November 2022
  112. WANG Y, Ma R, Zou Y, Wang W, et al
    The role of obstetrician-gynecologists and reproductive endocrinologists in the blood glucose management of polycystic ovary syndrome.
    Gynecol Endocrinol. 2022 Nov 29:1-7. doi: 10.1080/09513590.2022.2148649.
    PubMed     Abstract available


  113. LI M, Tian Y, Lv Y, Xu Y, et al
    The association between serum fatty acids and pregnancy in PCOS women undergoing ovulation induction.
    Gynecol Endocrinol. 2022 Nov 28:1-7. doi: 10.1080/09513590.2022.2148647.
    PubMed     Abstract available


  114. WANG R, Miao C, Chen Y, Zhao Y, et al
    Antioxidant supplements relieve insulin resistance but do not improve lipid metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials.
    Gynecol Endocrinol. 2022 Nov 28:1-13. doi: 10.1080/09513590.2022.2148648.
    PubMed     Abstract available


  115. AZIZ A, Shah M, Siraj S, Iqbal W, et al
    Association of vitamin D deficiency and vitamin D receptor (VDR) gene single-nucleotide polymorphism (rs7975232) with risk of preeclampsia.
    Gynecol Endocrinol. 2022 Nov 17:1-6. doi: 10.1080/09513590.2022.2146089.
    PubMed     Abstract available


  116. GU C, Zeng X, Shi Q, Xiao Q, et al
    Androgen-secreting adult granulosa cell tumor in a woman with polycystic ovary syndrome: a case report.
    Gynecol Endocrinol. 2022 Nov 11:1-3. doi: 10.1080/09513590.2022.2143491.
    PubMed     Abstract available


  117. YU X, Gao J, Huang Y, Zou Y, et al
    Effect of the increase rate of blood lipid concentration during pregnancy on the adverse pregnancy outcomes: a cohort study of 1051 singleton pregnancy.
    Gynecol Endocrinol. 2022 Nov 7:1-4. doi: 10.1080/09513590.2022.2138314.
    PubMed     Abstract available


  118. CAO LY, Zhang ZQ, Liu PP, Xu DF, et al
    Aberrant BMP15/HIF-1alpha/SCF signaling pathway in human granulosa cells is involved in the PCOS related abnormal follicular development.
    Gynecol Endocrinol. 2022;38:971-977.
    PubMed     Abstract available


  119. WANG W, Hao J, Shi Y
    IL23 suppresses proliferation and promotes apoptosis of human granulosa-like tumor cell line KGN by targeting the androgen receptor signal pathway.
    Gynecol Endocrinol. 2022;38:965-970.
    PubMed     Abstract available


    October 2022
  120. WU A, Yu R, Li D, Tuo Y, et al
    Expression and mechanism of micro-ribonucleic acid-29a in chorionic villi obtained at curettage with recurrent abortion.
    Gynecol Endocrinol. 2022 Oct 27:1-5. doi: 10.1080/09513590.2022.2136159.
    PubMed     Abstract available


  121. REGIDOR PA, Colli E
    The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.
    Gynecol Endocrinol. 2022 Oct 20:1-5. doi: 10.1080/09513590.2022.2134339.
    PubMed     Abstract available


  122. MIKUS M, Vitale SG, Coric M, Zajec V, et al
    State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Gynecol Endocrinol. 2022 Oct 13:1-7. doi: 10.1080/09513590.2022.2133105.
    PubMed     Abstract available


  123. TOLA EN, Bucak M, Togay A, Aslan Kosar P, et al
    The association between gestational diabetes mellitus and DNA damage in umbilical cord leukocytes and placental samples.
    Gynecol Endocrinol. 2022 Oct 12:1-5. doi: 10.1080/09513590.2022.2133104.
    PubMed     Abstract available


  124. YACOUB V, Carletti V, Grilli D, Morgani C, et al
    Quality of life and sexual function analysis in a group of Italian postmenopausal women after COVID-19 vaccination.
    Gynecol Endocrinol. 2022 Oct 6:1-4. doi: 10.1080/09513590.2022.2132224.
    PubMed     Abstract available


  125. KOSE C, Korpe B, Korkmaz V, Engin-Ustun Y, et al
    Is hemoglobin A1c valuable for predicting concurrent endometrial cancer in diabetic women with endometrial intraepithelial neoplasia?
    Gynecol Endocrinol. 2022 Oct 5:1-5. doi: 10.1080/09513590.2022.2129611.
    PubMed     Abstract available


  126. SHI X, Chen S, Yang Y, Liu L, et al
    Laparoscopic surgeries for uterine fibroids and ovarian cysts reduce ovarian reserve via age- and surgical type-manner.
    Gynecol Endocrinol. 2022 Oct 5:1-5. doi: 10.1080/09513590.2022.2128104.
    PubMed     Abstract available


  127. SONG H, Guan H, Tang H, Tang L, et al
    Effect of ovulation before or after intrauterine insemination on pregnancy outcome in patients with unexplained infertility or polycystic ovarian syndrome.
    Gynecol Endocrinol. 2022 Oct 2:1-5. doi: 10.1080/09513590.2022.2125952.
    PubMed     Abstract available


    September 2022
  128. CAGNACCI A, Londero AP
    Hormone therapy in endometrial cancer survivors: time for a change.
    Gynecol Endocrinol. 2022 Sep 28:1-2. doi: 10.1080/09513590.2022.2128105.
    PubMed    


  129. DE MATOS O, Ruthes EMP, Lenardt BCC, Beira de Andrade A, et al
    Relationship between postural changes, osteoarthritis and bone mineral density in postmenopausal women.
    Gynecol Endocrinol. 2022 Sep 23:1-5. doi: 10.1080/09513590.2022.2126454.
    PubMed     Abstract available


  130. LI Y, Hao Z
    Severe ovarian hyperstimulation syndrome induced by clomiphene: a case report.
    Gynecol Endocrinol. 2022 Sep 19:1-6. doi: 10.1080/09513590.2022.2122429.
    PubMed     Abstract available


  131. VALSAMAKIS G, Violetis O, Chatzakis C, Triantafyllidou O, et al
    Daughters of polycystic ovary syndrome pregnancies and androgen levels in puberty: a Meta-analysis.
    Gynecol Endocrinol. 2022 Sep 14:1-9. doi: 10.1080/09513590.2022.2121386.
    PubMed     Abstract available


  132. RUAN X
    Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy.
    Gynecol Endocrinol. 2022 Sep 14:1-6. doi: 10.1080/09513590.2022.2122432.
    PubMed     Abstract available


  133. FUENTES-CARRASCO M, Ruiz-Roman R, Saviron-Cornudella R, Perez-Roncero G, et al
    Systematic review and meta-analysis regarding maternal apelin in pregnant women with and without preeclampsia.
    Gynecol Endocrinol. 2022 Sep 12:1-10. doi: 10.1080/09513590.2022.2122433.
    PubMed     Abstract available


  134. CETINKAYA ALTUNTAS S, Celik O, Ozer U, Colak S, et al
    Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes.
    Gynecol Endocrinol. 2022 Sep 11:1-7. doi: 10.1080/09513590.2022.2118708.
    PubMed     Abstract available


  135. GRAHAM S, Archer DF, Simon JA, Ohleth KM, et al
    Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.
    Gynecol Endocrinol. 2022 Sep 8:1-20. doi: 10.1080/09513590.2022.2118254.
    PubMed     Abstract available


  136. ERTAS S, Unver G, Gonca Okumus Z, Yilmaz S, et al
    Maternal serum Sortilin-1 level as a potential biomarker for intrahepatic cholestasis of pregnancy.
    Gynecol Endocrinol. 2022 Sep 6:1-4. doi: 10.1080/09513590.2022.2119957.
    PubMed     Abstract available


  137. YILDIZ C, Caner A, Oksasoglu B, Misir S, et al
    The role of cytokeratin 19 levels in the determination of endometriosis stages.
    Gynecol Endocrinol. 2022 Sep 6:1-6. doi: 10.1080/09513590.2022.2120606.
    PubMed     Abstract available


  138. DA SILVA FR, Soares Thimoteo D, Ferraz Carbonel A, Fuchs LFP, et al
    Histomorphometric analysis of the endometrium in an ectopic model of endometriosis in mice.
    Gynecol Endocrinol. 2022 Sep 6:1-5. doi: 10.1080/09513590.2022.2119218.
    PubMed     Abstract available


  139. YANG M, Lin S, Zheng S, Sun A, et al
    A multicenter, randomized, open, controlled trial to evaluate the efficacy of Honglilai Vaginal Cream and Premarin Vaginal Cream for Genitourinary Syndrome of Menopause in different subgroups of Chinese postmenopausal women.
    Gynecol Endocrinol. 2022 Sep 6:1-7. doi: 10.1080/09513590.2022.2118710.
    PubMed     Abstract available


  140. QIU Y, Lin J, Xu Q, Zeng L, et al
    Effects of different doses of estrogen on ER expression and ovarian function in patients with unexplained recurrent abortion.
    Gynecol Endocrinol. 2022 Sep 5:1-5. doi: 10.1080/09513590.2022.2118707.
    PubMed     Abstract available


  141. JI X, Chen J, Xu P, Shen S, et al
    Effect of probiotics combined with metformin on improvement of menstrual and metabolic patterns in women with polycystic ovary syndrome: a randomized clinical trial.
    Gynecol Endocrinol. 2022 Sep 5:1-5. doi: 10.1080/09513590.2022.2119219.
    PubMed     Abstract available


  142. WU PY, Tan X, Wang M, Zheng X, et al
    Selenium supplementation for polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Gynecol Endocrinol. 2022 Sep 1:1-7. doi: 10.1080/09513590.2022.2118709.
    PubMed     Abstract available


  143. BARACAT EC, Baracat MCP, Jose M SJ Jr
    Are there new insights for the definition of PCOS?
    Gynecol Endocrinol. 2022;38:703-704.
    PubMed    


  144. SANG M, Wu Q, Tao Y, Huang F, et al
    Usage of mobile health interventions among overweight/obese PCOS patients undergoing assisted reproductive technology treatment during the COVID-19 pandemic.
    Gynecol Endocrinol. 2022;38:776-780.
    PubMed     Abstract available


  145. YUAN X, Huang Q, Li J, Yao Q, et al
    Bone morphogenetic protein-9 maybe an important factor which improves insulin resistance in PCOS.
    Gynecol Endocrinol. 2022;38:781-789.
    PubMed     Abstract available


    August 2022
  146. BI B, Jiang Y, Shi Y, Ruan F, et al
    Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Aug 28:1-9. doi: 10.1080/09513590.2022.2117294.
    PubMed     Abstract available


  147. PEREZ-LOPEZ FR, Wu JN, Yao L, Lopez-Baena MT, et al
    Apelin levels in pregnant women with and without gestational diabetes mellitus: a collaborative systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Aug 24:1-10. doi: 10.1080/09513590.2022.2114450.
    PubMed     Abstract available


  148. ZHU L, Zhang D, Yang Y
    A case of excision of ovarian torsion necrosis due to luteoma in a female who conceived a twin pregnancy through in vitro fertilization misdiagnosed with acute appendicitis.
    Gynecol Endocrinol. 2022 Aug 24:1-4. doi: 10.1080/09513590.2022.2114448.
    PubMed     Abstract available


  149. CAKINA S, Pek E, Ozkavak O, Kocyigit D, et al
    The role of paraoxonase and myeloperoxidase as oxidative stress markers in pregnant women with hypothyroidism.
    Gynecol Endocrinol. 2022 Aug 23:1-4. doi: 10.1080/09513590.2022.2114449.
    PubMed     Abstract available


  150. DENG K, Fu K, Hu Y, Zhang Y, et al
    The association between serum sex hormone-binding globulin changes during progestin-primed ovarian stimulation and embryo outcomes: a retrospective cohort study.
    Gynecol Endocrinol. 2022 Aug 21:1-5. doi: 10.1080/09513590.2022.2112940.
    PubMed     Abstract available


  151. BALIK AO, Vural F, Alpogan O, Ozogul M, et al
    The effects of testosterone on transgender males on carotid intima-media thickness and serum inflammatory markers compared within patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2022 Aug 21:1-5. doi: 10.1080/09513590.2022.2112942.
    PubMed     Abstract available


  152. DOU X, Jin X, Chen X, Zhou Q, et al
    Bu-Shen-Ning-Xin decoction alleviates premature ovarian insufficiency (POI) by regulating autophagy of granule cells through activating PI3K/AKT/mTOR pathway.
    Gynecol Endocrinol. 2022 Aug 21:1-11. doi: 10.1080/09513590.2022.2112941.
    PubMed     Abstract available


  153. ZAJEC V, Mikus M, Vitale SG, D'alterio MN, et al
    Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials.
    Gynecol Endocrinol. 2022 Aug 15:1-8. doi: 10.1080/09513590.2022.2109145.
    PubMed     Abstract available


  154. ZHANG C, Hu J, Wang X, Gu H, et al
    High level of homocysteine is associated with pre-eclampsia risk in pregnant woman: a meta-analysis.
    Gynecol Endocrinol. 2022 Aug 15:1-8. doi: 10.1080/09513590.2022.2110233.
    PubMed     Abstract available


  155. ORSATTI CL, Orsatti FL, Bezerra TG, Quevedo A, et al
    Interleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome.
    Gynecol Endocrinol. 2022 Aug 3:1-6. doi: 10.1080/09513590.2022.2105832.
    PubMed     Abstract available


  156. BERGA SL
    Brain phenotype in PCOS: androgens, anovulation, and gender.
    Gynecol Endocrinol. 2022;38:615-616.
    PubMed    


  157. MIAO J, Lu J, Tang J, Lu P, et al
    Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
    Gynecol Endocrinol. 2022;38:656-660.
    PubMed     Abstract available


  158. VURAL SOLAK GT, Akkus G, Solak Y, Kose S, et al
    Regional variability of modified Ferriman-Gallwey scorring in premenopausal healthy women in Southern Turkey.
    Gynecol Endocrinol. 2022;38:666-671.
    PubMed     Abstract available


  159. GENAZZANI AD, Battipaglia C, Petrillo T, Piacquadio N, et al
    Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index.
    Gynecol Endocrinol. 2022;38:681-688.
    PubMed     Abstract available


  160. MIN M, Ruan X, Wang H, Cheng J, et al
    Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients.
    Gynecol Endocrinol. 2022;38:676-680.
    PubMed     Abstract available


    July 2022
  161. WU D, Yu T, Shi H, Zhai J, et al
    Effect of elevated progesterone levels the day before ovulation on pregnancy outcomes in natural cycles of frozen thawed embryo transfer.
    Gynecol Endocrinol. 2022 Jul 28:1-5. doi: 10.1080/09513590.2022.2103671.
    PubMed     Abstract available


  162. ZHAO T, Zhang Q, Xiao X, Tao X, et al
    Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China.
    Gynecol Endocrinol. 2022 Jul 28:1-5. doi: 10.1080/09513590.2022.2104246.
    PubMed     Abstract available


  163. WANG Z, Yan J, Chen H, He L, et al
    The reproductive endocrine feature and conception outcome of women with unknown etiological menstrual cycle (36-45 days) with long follicular phase.
    Gynecol Endocrinol. 2022 Jul 26:1-6. doi: 10.1080/09513590.2022.2101636.
    PubMed     Abstract available


  164. DE ARRUDA GT, Driusso P, Rodrigues JC, de Godoy AG, et al
    Numerical rating scale for dysmenorrhea-related pain: a clinimetric study.
    Gynecol Endocrinol. 2022 Jul 19:1-5. doi: 10.1080/09513590.2022.2099831.
    PubMed     Abstract available


  165. PAFFONI A, Cesana S, Corti L, Ballabio E, et al
    Pregnancy rate in IVF patients with unexpected poor response to ovarian stimulation.
    Gynecol Endocrinol. 2022 Jul 17:1-6. doi: 10.1080/09513590.2022.2100339.
    PubMed     Abstract available


  166. GIANNINI A, Tebache L, Noti G, Cosimi G, et al
    Impact on ovarian reserve and fertility using carbon dioxide laser for endometriosis treatment: a systematic review.
    Gynecol Endocrinol. 2022 Jul 13:1-6. doi: 10.1080/09513590.2022.2087218.
    PubMed     Abstract available


  167. PINGARRON SANTOFIMIA C, Lafuente Gonzalez P, Guitierrez Velez MDC, Calvente Aguilar V, et al
    Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up.
    Gynecol Endocrinol. 2022;38:577-582.
    PubMed     Abstract available


  168. GU M, Ruan X, Li Y, Li T, et al
    Effect on the cardiovascular independent risk factor lipoprotein(a) in overweight or obese PCOS patients with ethinyl-estradiol/drospirenone alone or plus orlistat.
    Gynecol Endocrinol. 2022;38:598-602.
    PubMed     Abstract available


  169. AVSAR O, Derinoz N, Yilmaz F, Yilmaz M, et al
    Association between dopamine transporter gene (DAT1/SLC6A3) variants and infertility in the Turkish females.
    Gynecol Endocrinol. 2022;38:573-576.
    PubMed     Abstract available


    June 2022
  170. QI Y, Hou Y, Ma M, Li X, et al
    Circulating levels of Elabela in pregnant women with missed abortion.
    Gynecol Endocrinol. 2022 Jun 27:1-4. doi: 10.1080/09513590.2022.2090539.
    PubMed     Abstract available


  171. KORKMAZ H, Deveci CD, Alisik M, Korkmaz V, et al
    How do thiol disulfide balance and copper-ceruloplasmin levels change in women using copper intrauterine devices?
    Gynecol Endocrinol. 2022 Jun 27:1-4. doi: 10.1080/09513590.2022.2089650.
    PubMed     Abstract available


  172. XIA J, Yang Z, Ou X, Wu G, et al
    Evaluation of the relationship between serum TSH levels and pregnancy outcomes of IVF/ICSI patients in follicular phase long-acting long protocol.
    Gynecol Endocrinol. 2022 Jun 25:1-5. doi: 10.1080/09513590.2022.2091540.
    PubMed     Abstract available


  173. NICOLI F, Prete A, Citro F, Bertolotto A, et al
    Short sleep duration and risk of gestational diabetes.
    Gynecol Endocrinol. 2022 Jun 20:1-4. doi: 10.1080/09513590.2022.2089105.
    PubMed     Abstract available


  174. NAPPI RE, Tiranini L
    Polycystic ovary syndrome and sexuality.
    Gynecol Endocrinol. 2022 Jun 20:1-2. doi: 10.1080/09513590.2022.2089109.
    PubMed    


  175. ROTONDI M, Bendotti G, Croce L, Molteni M, et al
    A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism.
    Gynecol Endocrinol. 2022 Jun 20:1-5. doi: 10.1080/09513590.2022.2087216.
    PubMed     Abstract available


  176. MENICHINI D, Ughetti C, Monari F, Di Vinci PL, et al
    Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature.
    Gynecol Endocrinol. 2022 Jun 17:1-9. doi: 10.1080/09513590.2022.2089106.
    PubMed     Abstract available


  177. OZALTIN S, Celik HG, Kar E, Baran AK, et al
    Are antral follicle count and serum anti-Mullerian hormone level, as reliable markers of ovarian reserve, affected by UV radiation?
    Gynecol Endocrinol. 2022 Jun 17:1-5. doi: 10.1080/09513590.2022.2087217.
    PubMed     Abstract available


  178. OKYAY RE, Cetintas B, Akdoner A, Oztura I, et al
    The effect of oral contraceptive use on sympatic nerve activity in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2022 Jun 7:1-6. doi: 10.1080/09513590.2022.2082403.
    PubMed     Abstract available


  179. ROJEWSKA P, Meczekalski B, Bala G, Luisi S, et al
    From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
    Gynecol Endocrinol. 2022 Jun 1:1-6. doi: 10.1080/09513590.2022.2083104.
    PubMed     Abstract available


  180. KIESEL L
    Endometriosis - how should we classify?
    Gynecol Endocrinol. 2022;38:449.
    PubMed    


  181. RIBEIRO DIAS-JUNIOR A, Vieira da Motta E, Ferreira-Filho ES, Evangelista Oliveira-Junior ME, et al
    Hyperestrogenemia resulting from a granulosa cell tumor and causing pulmonary thromboembolism: a case report.
    Gynecol Endocrinol. 2022;38:531-533.
    PubMed     Abstract available


    May 2022
  182. ZHAO Q, He J
    Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials.
    Gynecol Endocrinol. 2022 May 27:1-11. doi: 10.1080/09513590.2022.2080194.
    PubMed     Abstract available


  183. YALLE-VASQUEZ S, Osco-Rosales K, Nieto-Gutierrez W, Benites-Zapata V, et al
    Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials.
    Gynecol Endocrinol. 2022 May 25:1-10. doi: 10.1080/09513590.2022.2079629.
    PubMed     Abstract available


  184. DEMIRAL SEZER S, Topaloglu O
    Effects of thyroid hormones in women with gestational diabetes.
    Gynecol Endocrinol. 2022 May 23:1-4. doi: 10.1080/09513590.2022.2076832.
    PubMed     Abstract available


  185. WANG T, Li Q
    Extratubal secondary trophoblastic implants (ESTI) following laparoscopic bilateral salpingectomy for ectopic pregnancy: problems that have been neglected for a long time.
    Gynecol Endocrinol. 2022 May 23:1-4. doi: 10.1080/09513590.2022.2078962.
    PubMed     Abstract available


  186. PASHAEI M, Mashayekhi F, Zahiri Z, Salehi Z, et al
    miR-203a-3p, ABL1 and TP63 gene expression is altered in the endometrium of women with endometriosis.
    Gynecol Endocrinol. 2022 May 19:1-5. doi: 10.1080/09513590.2022.2076830.
    PubMed     Abstract available


  187. LIU Q, Liu Z
    The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis.
    Gynecol Endocrinol. 2022 May 16:1-5. doi: 10.1080/09513590.2022.2071865.
    PubMed     Abstract available


  188. FU Y, Yang Y, Zhu L, Chen J, et al
    Effect of dietary n-6: n-3 Poly-Unsaturated fatty acids ratio on gestational diabetes mellitus: a prospective cohort.
    Gynecol Endocrinol. 2022 May 13:1-5. doi: 10.1080/09513590.2022.2073995.
    PubMed     Abstract available


  189. JIANG H, Xu Y, Cao L
    The protective effects of S14G-humanin on gestational diabetes mellitus symptoms.
    Gynecol Endocrinol. 2022 May 10:1-5. doi: 10.1080/09513590.2022.2073348.
    PubMed     Abstract available


  190. YANG J, Liu F, Li Y, Wu D, et al
    Forkhead box C2 is associated with insulin resistance in gestational diabetes mellitus.
    Gynecol Endocrinol. 2022 May 9:1-4. doi: 10.1080/09513590.2022.2072485.
    PubMed     Abstract available


  191. MONARI F, Menichini D, Salerno C, Donno V, et al
    Impact of endocrine disorders on stillbirth: a prospective cohort study.
    Gynecol Endocrinol. 2022 May 4:1-5. doi: 10.1080/09513590.2022.2069747.
    PubMed     Abstract available


    April 2022
  192. KAWKA-PACIORKOWSKA K, Breborowicz GH
    The role of corticoliberin concentration levels and placental CRH receptors 1 and 2 in the prolongation of pregnancy.
    Gynecol Endocrinol. 2022 Apr 27:1-5. doi: 10.1080/09513590.2022.2068521.
    PubMed     Abstract available


  193. HELOU CM, Zhao Z, Ding T, Anderson TL, et al
    Should body mass index replace age to drive the decision for endometrial sampling in premenopausal women with abnormal uterine bleeding?
    Gynecol Endocrinol. 2022 Apr 20:1-6. doi: 10.1080/09513590.2022.2058484.
    PubMed     Abstract available


  194. LI LH, Shi G, Pan JB, Wang CH, et al
    The expressions of matrix metalloproteinase-9, estrogen receptor, and progesterone receptor in thin endometrial tissue and their significance.
    Gynecol Endocrinol. 2022 Apr 15:1-7. doi: 10.1080/09513590.2022.2053957.
    PubMed     Abstract available


  195. LENG T, Li X, Zhang H
    Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial.
    Gynecol Endocrinol. 2022 Apr 15:1-7. doi: 10.1080/09513590.2022.2063831.
    PubMed     Abstract available


  196. CASTELO-BRANCO C, Navarro C, Beltran E, Losa F, et al
    Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.
    Gynecol Endocrinol. 2022 Apr 11:1-6. doi: 10.1080/09513590.2022.2056591.
    PubMed     Abstract available


  197. SAITO J, Kawasaki H, Adachi N, Sasaki A, et al
    Diazoxide during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum: a case report.
    Gynecol Endocrinol. 2022 Apr 9:1-3. doi: 10.1080/09513590.2022.2061453.
    PubMed     Abstract available


  198. JIN L, Ruan X, Jin J, Wang Y, et al
    Infertile women with endometriosis possess differences in cytokine levels in various tissues.
    Gynecol Endocrinol. 2022 Apr 9:1-5. doi: 10.1080/09513590.2022.2060961.
    PubMed     Abstract available


  199. GIORDANO LA, Giordano MV, Celia Teixeira Gomes R, Dos Santos Simoes R, et al
    Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls.
    Gynecol Endocrinol. 2022 Apr 8:1-8. doi: 10.1080/09513590.2022.2061454.
    PubMed     Abstract available


  200. KAYACIK GUNDAY O, Aldemir O, Ozelci R, Dilbaz S, et al
    Supraphysiological hCG day estradiol levels can predict pregnancy-associated plasma protein A levels in maternal serum in the first trimester.
    Gynecol Endocrinol. 2022 Apr 6:1-6. doi: 10.1080/09513590.2022.2057946.
    PubMed     Abstract available


    March 2022
  201. LIU Q, Wei S, Wang F
    Prothrombotic state and calcium deficiency in early pregnancy are risk factors for gestational diabetes mellitus: a retrospective cohort study.
    Gynecol Endocrinol. 2022 Mar 28:1-4. doi: 10.1080/09513590.2022.2047170.
    PubMed     Abstract available


  202. KIZILKAYA Y, Ibanoglu MC, Kiykac Altinbas S, Engin-Ustun Y, et al
    A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms.
    Gynecol Endocrinol. 2022 Mar 23:1-4. doi: 10.1080/09513590.2022.2053956.
    PubMed     Abstract available


  203. ZHANG Y, Xu L
    Comparative study of DHEA and letrozole induced polycystic ovary syndrome in post-pubertal rats.
    Gynecol Endocrinol. 2022 Mar 21:1-7. doi: 10.1080/09513590.2022.2052843.
    PubMed     Abstract available


  204. ZHANG J, Huang J, He X, Li N, et al
    Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model.
    Gynecol Endocrinol. 2022 Mar 14:1-6. doi: 10.1080/09513590.2022.2034147.
    PubMed     Abstract available


  205. WANG L, Lai D
    The evaluation of ovarian function in normosmic idiopathic hypogonadotropic hypogonadism with a fibroblast growth factor receptor 1 mutation: a case report.
    Gynecol Endocrinol. 2022 Mar 11:1-4. doi: 10.1080/09513590.2022.2045580.
    PubMed     Abstract available


  206. BADR DA, Kassem C, Carlin A, Dobrescu O, et al
    Antenatal insulin therapy in gestational diabetes mellitus: validation of the new Brugmann scores.
    Gynecol Endocrinol. 2022 Mar 11:1-5. doi: 10.1080/09513590.2022.2048296.
    PubMed     Abstract available


  207. MAFFEI S, Franchini M, Fortunato L, Guiducci L, et al
    Long-term effects of a combination of isoflavones, agnus castus and magnolia extracts on climacteric symptoms and cardiometabolic risk profile in postmenopausal women.
    Gynecol Endocrinol. 2022 Mar 8:1-6. doi: 10.1080/09513590.2022.2047171.
    PubMed     Abstract available


  208. TAJADA M, Dieste-Perez P, Sanz-Arenal A, Perez-Roncero G, et al
    Leukocyte telomere length in women with and without polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Mar 7:1-7. doi: 10.1080/09513590.2022.2047922.
    PubMed     Abstract available


  209. WU W, Xu GF, Hu YJ
    The therapeutic effect of granulocyte colony stimulating factor (G-CSF) on potential biochemical pregnancy in patients with unexplained repeated transplantation failure (RIF): a case series and literature review.
    Gynecol Endocrinol. 2022 Mar 4:1-5. doi: 10.1080/09513590.2022.2036716.
    PubMed     Abstract available


  210. WEN Z, Qiaoqian Z, Wen S, Yonghong W, et al
    Clinical changes of leptin/ghrelin and PAI-1 levels in adolescent girls with abnormal uterine bleeding-ovulatory dysfunction.
    Gynecol Endocrinol. 2022 Mar 3:1-5. doi: 10.1080/09513590.2022.2045938.
    PubMed     Abstract available


  211. VANNUCCINI S, Biagiotti C, Esposto MC, La Torre F, et al
    Long-term treatment of endometriosis-related pain among women seeking hormonal contraception.
    Gynecol Endocrinol. 2022 Mar 3:1-5. doi: 10.1080/09513590.2022.2047172.
    PubMed     Abstract available


  212. CAPOZZI A, Scambia G, Lello S
    Subclinical hypothyroidism in women's health: from pre- to post-menopause.
    Gynecol Endocrinol. 2022 Mar 3:1-11. doi: 10.1080/09513590.2022.2046728.
    PubMed     Abstract available


  213. OLUKLU D, Menekse Beser D, Uyan Hendem D, Sinaci S, et al
    Maternal serum midkine level increases in pregnant women with diabetes mellitus: a case-control study.
    Gynecol Endocrinol. 2022 Mar 3:1-4. doi: 10.1080/09513590.2022.2045937.
    PubMed     Abstract available


  214. TONG J, Xiang L, Niu Y, Zhang T, et al
    Effect of orlistat intervention on in vitro fertilization/intracytoplasmic sperm injection outcome in overweight/obese infertile women.
    Gynecol Endocrinol. 2022;38:253-257.
    PubMed     Abstract available


    February 2022
  215. WANG W, Cao YM, Cai NN, Guo Q, et al
    Influence of one-day diabetes mellitus clinic management on blood glucose control and prognosis in patients with gestational diabetes mellitus.
    Gynecol Endocrinol. 2022 Feb 21:1-5. doi: 10.1080/09513590.2022.2040474.
    PubMed     Abstract available


  216. LIU M, Mai Z, Lin H, Li Y, et al
    Does elevated luteinizing hormone level before trigger mean premature luteinizing hormone surge in advanced-aged women undergoing mild ovarian stimulation?
    Gynecol Endocrinol. 2022 Feb 10:1-4. doi: 10.1080/09513590.2022.2037546.
    PubMed     Abstract available


  217. RAJASEKARAN K, Malhotra N, Mahey R, Khadgawat R, et al
    Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study.
    Gynecol Endocrinol. 2022;38:140-147.
    PubMed     Abstract available


    January 2022
  218. VIVEK K, Thangappazham B, Vykunta A, Kulkarni PP, et al
    Maternal serum irisin levels in normotensive and preeclamptic pregnancies: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2022 Jan 10:1-8. doi: 10.1080/09513590.2021.2025217.
    PubMed     Abstract available


  219. KONG M, Zhang H, Liu X, Ge Y, et al
    Association of maternal neutrophil count in early pregnancy with the development of gestational diabetes mellitus: a prospective cohort study in China.
    Gynecol Endocrinol. 2022 Jan 8:1-5. doi: 10.1080/09513590.2021.2025216.
    PubMed     Abstract available


  220. LI M, Ruan X, Ju R, Min M, et al
    Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?
    Gynecol Endocrinol. 2022 Jan 7:1-5. doi: 10.1080/09513590.2021.2016694.
    PubMed     Abstract available


  221. CHEDRAUI P
    The future of gynecological endocrinology.
    Gynecol Endocrinol. 2022;38:1.
    PubMed    


    December 2021
  222. ZHANG J, Huang J, He X, Li N, et al
    Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model.
    Gynecol Endocrinol. 2021 Dec 29:1-6. doi: 10.1080/09513590.2021.2011198.
    PubMed     Abstract available


  223. MENDOZA N, Losa F, Palacios S
    Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants.
    Gynecol Endocrinol. 2021 Dec 21:1-4. doi: 10.1080/09513590.2021.2015759.
    PubMed     Abstract available


  224. BUGGIO L, Barbara G, Facchin F, Ghezzi L, et al
    The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature.
    Gynecol Endocrinol. 2021 Dec 16:1-9. doi: 10.1080/09513590.2021.2016693.
    PubMed     Abstract available


  225. WANG L, Yao H, Shen W, Wang X, et al
    Gestational diabetes mellitus is associated with blood inflammatory indicators in a Chinese pregnant women population.
    Gynecol Endocrinol. 2021 Dec 15:1-5. doi: 10.1080/09513590.2021.2015762.
    PubMed     Abstract available


  226. LU L, Wang Z, Zhang H, Liu T, et al
    Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation.
    Gynecol Endocrinol. 2021 Dec 15:1-5. doi: 10.1080/09513590.2021.2015760.
    PubMed     Abstract available


  227. TAN X, Huang Y
    Magnesium supplementation for glycemic status in women with gestational diabetes: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2021 Dec 15:1-5. doi: 10.1080/09513590.2021.1988558.
    PubMed     Abstract available


  228. LI C, Gao C, Zhang X, Zhang L, et al
    Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials.
    Gynecol Endocrinol. 2021 Dec 15:1-7. doi: 10.1080/09513590.2021.2015761.
    PubMed     Abstract available


  229. MOCCIA P, Belda-Montesinos R, Monllor-Tormos A, Chedraui P, et al
    Body weight and fat mass across the menopausal transition: hormonal modulators.
    Gynecol Endocrinol. 2021 Dec 13:1-6. doi: 10.1080/09513590.2021.2004395.
    PubMed     Abstract available


  230. PODFIGURNA A, Szeliga A, Horwat P, Maciejewska-Jeske M, et al
    Hyperthyroidism associated with struma ovarii - a case report and review of literature.
    Gynecol Endocrinol. 2021;37:1143-1150.
    PubMed     Abstract available


  231. WANG A, Huang S, Liu M, Wang B, et al
    Clinical exome sequencing identifies novel compound heterozygous mutations of the WEE2 gene in primary infertile women with fertilization failure.
    Gynecol Endocrinol. 2021;37:1096-1101.
    PubMed     Abstract available


    November 2021
  232. HERNANDEZ-JIMENEZ JL, Barrera D, Espinoza-Simon E, Gonzalez J, et al
    Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.
    Gynecol Endocrinol. 2021 Nov 17:1-8. doi: 10.1080/09513590.2021.2003326.
    PubMed     Abstract available


  233. VARIKASUVU SR, Perez-Lopez FR, Thangappazham B, Raj H, et al
    Effect of metformin intervention on circulating irisin levels in polycystic ovary syndrome: a systematic review and collaborative meta-analysis.
    Gynecol Endocrinol. 2021 Nov 15:1-6. doi: 10.1080/09513590.2021.1998439.
    PubMed     Abstract available


  234. PEREZ-LOPEZ FR, Lopez-Baena MT, Varikasuvu SR, Ruiz-Roman R, et al
    Preeclampsia and gestational hypertension are associated to low maternal circulating kisspeptin levels: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2021 Nov 15:1-8. doi: 10.1080/09513590.2021.2004396.
    PubMed     Abstract available


  235. JI M, Yuan M, Jiao X, Li Q, et al
    A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
    Gynecol Endocrinol. 2021 Nov 9:1-6. doi: 10.1080/09513590.2021.2000961.
    PubMed     Abstract available


  236. KRUSZEWSKA J, Laudy-Wiaderny H, Krzywdzinska S, Grymowicz M, et al
    Two consecutive pregnancies in a patient with premature ovarian insufficiency in the course of classic galactosemia and a review of the literature.
    Gynecol Endocrinol. 2021 Nov 3:1-4. doi: 10.1080/09513590.2021.1998437.
    PubMed     Abstract available


    October 2021
  237. INDHAVIVADHANA S, Boonyachan W, Rattanachaiyanont M, Wongwananuruk T, et al
    Effectiveness of vitamin D2 supplementation on high-sensitivity C-reactive protein and other metabolic indices in menopausal Thai women: a randomized-controlled trial.
    Gynecol Endocrinol. 2021 Oct 27:1-7. doi: 10.1080/09513590.2021.1988560.
    PubMed     Abstract available


  238. CARETTO M, Simoncini T
    Progestin or anti-estrogen treatment for endometrial cancer: choosing the best option for selected patients.
    Gynecol Endocrinol. 2021 Oct 26:1-2. doi: 10.1080/09513590.2021.1995964.
    PubMed    


  239. DORI-DAYAN N, Cukierman-Yaffe T, Kedar N, Zemet R, et al
    Maternal glucose variability during pregnancy & birthweight percentile in women with pre-gestational diabetes.
    Gynecol Endocrinol. 2021 Oct 21:1-5. doi: 10.1080/09513590.2021.1993814.
    PubMed     Abstract available


  240. WU H, Zheng X, Liu Y, Shen J, et al
    Hsa_circRNA_102682 is closely related to lipid metabolism in gestational diabetes mellitus.
    Gynecol Endocrinol. 2021 Oct 19:1-5. doi: 10.1080/09513590.2021.1991911.
    PubMed     Abstract available


  241. KARAMALI M, Gholizadeh M
    The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2021 Oct 19:1-5. doi: 10.1080/09513590.2021.1991910.
    PubMed     Abstract available


  242. GRANDI G, Del Savio MC, Melotti C, Feliciello L, et al
    Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study.
    Gynecol Endocrinol. 2021 Oct 16:1-5. doi: 10.1080/09513590.2021.1991909.
    PubMed     Abstract available


  243. SHEN Y, Li J, Tian H, Ji Y, et al
    High level of complement factor Ba within first prenatal test of gestation increases the risk of subsequent gestational diabetes: a propensity score-matched study.
    Gynecol Endocrinol. 2021 Oct 13:1-6. doi: 10.1080/09513590.2021.1989400.
    PubMed     Abstract available


  244. LEE KW, Tan SF, Omar A, Nasir NH, et al
    Effectiveness of system-based intervention in reducing incidence of type 2 diabetes and to improve the postnatal metabolic profiles in women with gestational diabetes mellitus A: randomized controlled study.
    Gynecol Endocrinol. 2021 Oct 12:1-8. doi: 10.1080/09513590.2021.1988561.
    PubMed     Abstract available


  245. LIAO D, Liu X, Yuan X, Feng P, et al
    Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2021 Oct 11:1-6. doi: 10.1080/09513590.2021.1988559.
    PubMed     Abstract available


  246. CHENG CC, Ting-An, Chang, Yang WP, et al
    First case report of papillary thyroid carcinoma arising within a functional teratoma in Graves' disease patient.
    Gynecol Endocrinol. 2021;37:955-958.
    PubMed     Abstract available


  247. BAHCECI E, Kaya C, Karakas S, Yildiz S, et al
    Serum X-box-binding protein 1 levels in PCOS patients.
    Gynecol Endocrinol. 2021;37:920-924.
    PubMed     Abstract available


    September 2021
  248. ABOSHAMA RA, Islam BA, Motaal AOA, Labib K, et al
    Effect of piroxicam administration in infertile women undergoing assisted reproductive technologies: A systematic review and meta-analysis.
    Gynecol Endocrinol. 2021;37:785-791.
    PubMed     Abstract available


    August 2021
  249. NIE L, Zou H, Ma X, Cheng L, et al
    A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients.
    Gynecol Endocrinol. 2021;37:735-739.
    PubMed     Abstract available


  250. DADACHANJI R, Sawant D, Patil A, Mukherjee S, et al
    Replication study of THADA rs13429458 variant with PCOS susceptibility and its related traits in Indian women.
    Gynecol Endocrinol. 2021;37:716-720.
    PubMed     Abstract available


  251. MECZEKALSKI B, Szeliga A, Maciejewska-Jeske M, Podfigurna A, et al
    Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Gynecol Endocrinol. 2021;37:677-682.
    PubMed     Abstract available


    July 2021
  252. BARBANTI C, Centini G, Lazzeri L, Habib N, et al
    Adenomyosis and infertility: the role of the junctional zone.
    Gynecol Endocrinol. 2021;37:577-583.
    PubMed     Abstract available


  253. GUNTHER V, Otte SV, Freytag D, Maass N, et al
    Recurrent implantation failure - an overview of current research.
    Gynecol Endocrinol. 2021;37:584-590.
    PubMed     Abstract available


    June 2021
  254. CARETTO M, Simoncini T
    The need to reduce gonadotoxicity! fertility reserve after chemotherapy for gynaecological cancer.
    Gynecol Endocrinol. 2021;37:481-482.
    PubMed    


  255. DI TUCCI C, Galati G, Mattei G, Bonanni V, et al
    The role of alpha lipoic acid in female and male infertility: a systematic review.
    Gynecol Endocrinol. 2021;37:497-505.
    PubMed     Abstract available


  256. PINGARRON C, de Lafuente P, Ierullo AM, Poyo Torcal S, et al
    Ospemifene in clinical practice for vulvo-vaginal atrophy: results at 3 months of follow-up of use.
    Gynecol Endocrinol. 2021;37:562-566.
    PubMed     Abstract available


  257. CECCHINO GN, Roque M, Cerrillo M, Filho RDR, et al
    DuoStim cycles potentially boost reproductive outcomes in poor prognosis patients.
    Gynecol Endocrinol. 2021;37:519-522.
    PubMed     Abstract available


  258. CECCHINO GN, Pacheco A, Garcia-Velasco JA
    Reproductive senescence and energetic metabolism of human luteinized granulosa cells: is it all about ATP? A prospective cohort and critical view.
    Gynecol Endocrinol. 2021;37:523-527.
    PubMed     Abstract available


    May 2021
  259. WANG L, Wen X, Lv S, Tian S, et al
    Effects of vitamin D supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Gynecol Endocrinol. 2021;37:446-455.
    PubMed     Abstract available


  260. ISIK G, Oktem M, Guler I, Oktem E, et al
    The impact of granulocyte colony-stimulating factor (G-CSF) on thin endometrium of an animal model with rats.
    Gynecol Endocrinol. 2021;37:438-445.
    PubMed     Abstract available


  261. YIN XD, Xue XO, Wang JS, Yang W, et al
    Effect of Bushen Huoxue recipe on women with thin endometrial ovulation disorder and a rat model of thin endometrium resulted from kidney deficiency-related blood stasis.
    Gynecol Endocrinol. 2021;37:433-437.
    PubMed     Abstract available


    April 2021
  262. PRABHAKAR P, Mahey R, Gupta M, Khadgawat R, et al
    Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial.
    Gynecol Endocrinol. 2021;37:332-336.
    PubMed     Abstract available


  263. ZHANG N, Zhuang L, Gai S, Shan Y, et al
    Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model.
    Gynecol Endocrinol. 2021;37:337-341.
    PubMed     Abstract available


    March 2021
  264. LI M, Jia M, Zhao X, Shi R, et al
    A new NLRP5 mutation causes female infertility and total fertilization failure.
    Gynecol Endocrinol. 2021;37:283-284.
    PubMed     Abstract available


  265. ATASAYAN K, Yoldemir T
    The effect of PCOS status on atherosclerosis markers and cardiovascular disease risk factors in young women with vitamin D deficiency.
    Gynecol Endocrinol. 2021;37:225-229.
    PubMed     Abstract available


  266. BULLETTI C, Allegra A, Mignini Renzini M, Vaiarelli A, et al
    How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus.
    Gynecol Endocrinol. 2021;37:255-263.
    PubMed     Abstract available


  267. ASHRAF S, Rasool SUA, Nabi M, Ganie MA, et al
    CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome.
    Gynecol Endocrinol. 2021;37:230-234.
    PubMed     Abstract available


  268. BEZERRA ESPINOLA MS, Bilotta G, Aragona C
    Positive effect of a new supplementation of vitamin D3 with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study.
    Gynecol Endocrinol. 2021;37:251-254.
    PubMed     Abstract available


    February 2021
  269. SHARMA P, Kaur M, Khetarpal P
    CYP19 gene rs2414096 variant and differential genetic risk of polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2021;37:126-131.
    PubMed     Abstract available


  270. SHI M, Huang W, Shu L, Hou G, et al
    Research on polycystic ovary syndrome: a bibliometric analysis from 2009 to 2019.
    Gynecol Endocrinol. 2021;37:121-125.
    PubMed     Abstract available


  271. KARAMAN S, Sabanciogullari E, Karaman E, Basaranoglu M, et al
    Indicator of early kidney injury in adolescents with polycystic ovary syndrome: Can urine NGAL level be?
    Gynecol Endocrinol. 2021;37:117-120.
    PubMed     Abstract available


  272. ZAMANIYAN M, Peyvandi S, Heidaryan Gorji H, Moradi S, et al
    Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial.
    Gynecol Endocrinol. 2021;37:141-145.
    PubMed     Abstract available


    January 2021
  273. NAPPI RE, Palacios S, Bruyniks N, Particco M, et al
    The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy.
    Gynecol Endocrinol. 2021;37:78-82.
    PubMed     Abstract available


  274. TAGHIZADEH S, Izadi A, Shirazi S, Parizad M, et al
    The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Gynecol Endocrinol. 2021;37:26-30.
    PubMed     Abstract available


  275. DORETTO-SILVA L, Steiner ML, Veridiano JM, Petri G, et al
    White, brown, and bone marrow adipose tissue behavior in DHEA-induced PCOS mice.
    Gynecol Endocrinol. 2021;37:15-20.
    PubMed     Abstract available


  276. BAHADUR A, Mundhra R, Kashibhatla J, Rajput R, et al
    Prevalence of metabolic syndrome among women with different PCOS phenotypes - a prospective study.
    Gynecol Endocrinol. 2021;37:21-25.
    PubMed     Abstract available


  277. ATAKUL T, Tayyar AT, Turan OD, Celik SY, et al
    An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
    Gynecol Endocrinol. 2021;37:46-50.
    PubMed     Abstract available


  278. RADZINSKY VE, Ramazanova FU, Khamoshina MB, Azova MM, et al
    Vitamin D insufficiency as a risk factor for reproductive losses in miscarriage.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  279. FODINA V, Dudorova A, Erenpreiss J
    Evaluation of embryo aneuploidy (PGT-A) and endometrial receptivity (ERA) testing in patients with recurrent implantation failure in ICSI cycles.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  280. MIKHAILOVA VA, Markova KL, Belikova ME, Gzgzyan AM, et al
    T-Lymphocyte proliferative activity in early pregnancy and outside pregnancy state.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  281. ORAZOV MR, Radzinskiy VE, Kostin IN, Gagaev CG, et al
    Endometrial asynchrony in pathogenesis of implantation impairment in women with infertility associated with endometriosis.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  282. OB'EDKOVA KV, Kogan IY, Muller VC, Tapilskaya NI, et al
    IVF protocol efficacy in women with expected suboptimal response depending on ovary stimulation mode.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  283. NAZARENKO TA, Martirosyan YO, Birukova AM, Korneeva IE, et al
    Outcomes of ovarian stimulation in the follicular and luteal phases of the menstrual cycle in cancer patients.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  284. KAPUSTIN RV, Kopteeva EV, Alekseenkova EN, Tral TG, et al
    Placental expression of endoglin, placental growth factor, leptin, and hypoxia-inducible factor-1 in diabetic pregnancy and pre-eclampsia.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  285. BAKLEICHEVA M, Bespalova O, Kovaleva I
    Features of the 1st trimester of pregnancy course with severe deficiency of 25(OH)D.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  286. YARMOLINSKAYA M, Denisova A, Tkachenko N, Ivashenko T, et al
    Vitamin D significance in pathogenesis of endometriosis.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  287. YARMOLINSKAYA M, Bulgakova O, Abashova E, Borodina V, et al
    The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


  288. MAMEDALIEVA NM, Kurmanova AM, Baikoshkarova SB, Issenova S, et al
    The effectiveness of micronized progesterone in the complex therapy of 'thin endometry' syndrome.
    Gynecol Endocrinol. 2021;37.
    PubMed     Abstract available


    September 2020
  289. ZHAO Y, Luan X, Wang Y
    Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study.
    Gynecol Endocrinol. 2020 Sep 16:1-5. doi: 10.1080/09513590.2020.1807502.
    PubMed     Abstract available


    June 2020
  290. BATTAGLIA C, Battaglia B, Casadio P, Rizzo R, et al
    Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
    Gynecol Endocrinol. 2020 Jun 16:1-8. doi: 10.1080/09513590.2020.1770213.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.